Pascal Deschatelets Sells 12,000 Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Stock

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) insider Pascal Deschatelets sold 12,000 shares of Apellis Pharmaceuticals stock in a transaction dated Monday, July 10th. The shares were sold at an average price of $84.55, for a total value of $1,014,600.00. Following the completion of the transaction, the insider now owns 1,046,813 shares in the […]

Related Keywords

United States ,America ,Pascal Deschatelets ,Vanguard Group Inc ,Citigroup ,News Ratings For Apellis Pharmaceuticals Daily ,Apellis Pharmaceuticals Company Profile ,Norges Bank ,Wells Fargo Company ,Nasdaq ,Quarter For Apellis Pharmaceuticals ,Apellis Pharmaceuticals Inc ,Apellis Pharmaceuticals Stock Down ,Pricet Rowe Associates Inc ,Securities Exchange Commission ,Apellis Pharmaceuticals ,Hedge Funds Weigh In On Apellis Pharmaceuticals ,Get Free Report ,Exchange Commission ,Pharmaceuticals Stock Down ,State Street Corp ,Street Corp ,Apellis Pharmaceuticals Daily ,